WSBFX Performance — Boston Trust Walden Balanced Fund
Data updated: 2026-08-26
WSBFX returned +8.10% year to date and +17.93% over one year to Jun 2026. Annualised returns are +10.34% over 3 years and +6.07% over 5 years. Against its US Large Blend category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $134, against $157 for the category, and to $118 over one year, against $118. Volatility over the past three years was 8.65% a year. In the 12 months to Jun 2026 the fund lost a net $23.8M, and assets reached $142.57M.
WSBFX Growth of $100
What $100 invested in Boston Trust Walden Balanced Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | WSBFX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $118 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $134 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $134 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $174 | $229 |
WSBFX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.10% |
| 1 year | +17.93% |
| 3 years (annualised) | +10.34% |
| 5 years (annualised) | +6.07% |
WSBFX Annual Returns
Calendar-year total returns of Boston Trust Walden Balanced Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +8.10% |
| 2025 | +10.66% |
| 2024 | +6.88% |
| 2023 | +12.18% |
| 2022 | −13.67% |
| 2021 | +19.37% |
| 2020 | +8.27% |
| 2019 (Jul–Dec) | +8.76% |
WSBFX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.3% | +1.1% | −4.3% | +5.7% | +1.5% | +2.8% | — | — | — | — | — | — |
| 2025 | +2.8% | −1.3% | −3.0% | −1.4% | +2.3% | +2.2% | +0.6% | +2.3% | +2.5% | +2.1% | +1.7% | −0.3% |
| 2024 | +0.5% | +1.0% | +1.9% | −3.8% | +2.5% | +1.4% | +1.6% | +2.0% | +0.9% | −2.0% | +3.5% | −2.7% |
| 2023 | +3.6% | −2.9% | +2.7% | +1.7% | −1.8% | +3.6% | +2.5% | −1.3% | −3.8% | −1.6% | +6.0% | +3.4% |
| 2022 | −4.7% | −2.5% | +1.1% | −6.6% | +0.7% | −5.3% | +6.7% | −3.0% | −7.2% | +5.9% | +5.2% | −3.6% |
| 2021 | −1.8% | +2.0% | +3.1% | +4.2% | +0.8% | +1.6% | +2.9% | +1.9% | −4.2% | +5.4% | −1.4% | +3.8% |
| 2020 | −0.2% | −6.3% | −8.2% | +6.5% | +3.1% | +0.4% | +3.7% | +4.0% | −1.6% | −1.5% | +6.7% | +2.6% |
| 2019 | — | — | — | — | — | — | +1.6% | −0.5% | +1.7% | +0.9% | +2.4% | +2.3% |
WSBFX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 8.65%
- 3-year Sharpe ratio: 0.68 (vs 4.5% risk-free rate)
- Best month: +6.01% (Nov 2023)
- Worst month: −4.28% (Mar 2026)
WSBFX Fund Flows
Monthly money in and out of Boston Trust Walden Balanced Fund, from SEC Form N-PORT.
- 12-month net flow: −$23.8M
- 12-month gross sales (incl. reinvestments): $10.8M
- Sales ÷ redemptions: 0.31×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $200K | $1.2M | −$1.0M |
| May 2026 | $82K | $4.4M | −$4.3M |
| Apr 2026 | $116K | $1.7M | −$1.6M |
| Mar 2026 | $447K | $3.7M | −$3.3M |
| Feb 2026 | $183K | $4.6M | −$4.4M |
| Jan 2026 | $493K | $3.1M | −$2.6M |
| Dec 2025 | $7.7M | $1.9M | $5.8M |
| Nov 2025 | $374K | $4.1M | −$3.7M |
| Oct 2025 | $486K | $4.3M | −$3.8M |
| Sep 2025 | $258K | $697K | −$439K |
| Aug 2025 | $235K | $1.7M | −$1.5M |
| Jul 2025 | $149K | $3.1M | −$2.9M |
WSBFX Assets Under Management
Net assets of Boston Trust Walden Balanced Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $142.57M |
| 2026-03-31 | $135.85M |
| 2025-12-31 | $148.74M |
| 2025-09-30 | $156.66M |
| 2025-06-30 | $153.30M |
| 2025-03-31 | $151.68M |
| 2024-12-31 | $157.65M |
| 2024-09-30 | $166.08M |
| 2024-06-28 | $161.48M |
| 2024-03-28 | $166.92M |
| 2023-12-29 | $165.56M |
| 2023-09-30 | $156.36M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.